Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors

Brain Research Bulletin

Volumn 39, Issue 6, 1996, Pages 349-357

  Wang, John Q ^a   McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Behavior; Cortex; Glutamate; Immediate early gene; Nucleus accumbens; Opioid

Indexed keywords

AMPA RECEPTOR; MESSENGER RNA; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREPROENKEPHALIN; PRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0029988762     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(96)00002-0     Document Type: Article

References (59)

1. Albin, R. L.; Makowiec, R. L.; Hollingsworth, Z. R.; Dure, L. S. IV; Penney, J. B.; Young, A. B. Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study. Neuroscience 46:35-48; 1992.
2. Berretta, S.; Robertson, H. A.; Graybiel, A. M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68:767-777; 1992.
3. Bristow, L. J.; Thorn, L.; Tricklebank, M. D.; Hutson, P. H. Competitive NMDA receptor antagonists attenuate the behavioral and neurochemical effects of amphetamine in mice. Eur. J. Pharmacol. 264:353-359; 1994.
4. Donzanti, B. A.; Uretski, N. J. Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens, Naunyn Schmied. Arch. Pharmacol. 325:1-7; 1984.
5. Dragunow, M.; Logan, B.; Laverty, R. 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: Reversal with MK-801. Eur. J. Pharmacol. 206:255-258; 1991.
6. 3H]Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding to rat striatal membranes: Effects of selective brain lesions, J. Neurochem. 51:579-586; 1988.
7. Freed, W. J. Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci. Biobehav. Rev. 18:111-120; 1994.
8. Garcia-Munoz, M.; Young, S. J.; Groves, P. M. Terminal excitability of the corticostriatal pathway: II. Regulation by glutamate receptor stimulation. Brain Res. 551:207-215; 1991.
9. Ginty, D. D.; Bading, H.; Greenberg, M. E. Trans-synaptic regulation of gene expression. Curr. Opin. Neurobiol. 2:312-316; 1992.
10. Greenamyre, J. T.; Young, A. B. Synaptic localization of striatal NMDA, quisqualate and kainate receptors. Neurosci. Lett. 101:133-137; 1989.
11. Hagihara, K.; Tsumoto, T.; Sato, H.; Hata, Y. Actions of excitatory amino acid antagonists on geniculo-cortical transmission in the cat's visual cortex. Exp. Brain Res. 69:407-416; 1988.
12. Johnson, M.; Bush, L. G.; Gibb, J. W.; Hanson, G. R. Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A system. Eur. J. Pharmacol. 193:367-370; 1991.
13. Johnson, M.; Bush, L. G.; Gibb, J. W.; Hanson, G. R. Role of N-methyl-D-aspartate (NMDA) receptors in the response of extrapyramidal neurotension and dynorphin A system to cocaine and GBR 12909. Biochem. Pharmacol. 41:649-652; 1991.
14. Karler, R.; Calder, L. D.; Chaudhry, I. A.; Turkanis, S. A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:599-606; 1989.
15. Karler, R.; Calder, L. D.; Bedingfield, J. B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology 115:305-310; 1994.
16. Karler, R.; Calder, L. D.; Thai, L. H.; Bedingfield, J. B. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 658:8-14; 1994.
17. Karler, R.; Calder, L. D.; Thai, L. H.; Bedingfield, J. B. The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res. 671:100-104; 1995.
18. Karler, R.; Calder, L. D.; Turkanis, S. A. DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552:295-300; 1991.
19. Karler, R.; Chaudhry, I. A.; Calder, L. D.; Turkanis, S. A. Amphetamine sensitization and the excitatory amino acids. Brian Res. 537:76-82; 1990.
20. Kelley, A. E.; Throne, L. C. NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29:247-254; 1992.
21. Layer, R. T.; Uretsky, N. J.; Wallace, L. J. Effects of the AMPA/ kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res. 617:267-273; 1993.
22. Martinez-Fong, D.; Rosales, M. G.; Gongora-Alfaro, J. L.; Hernandez, S.; Aceves, J. NMDA receptor mediates dopamine release in the striatum of unanesthestized rats as measured by brain microdialysis. Brain Res. 595:309-315; 1992.
23. Miller, K. D.; Chapman, B.; Stryker, M. P. Visual responses in adult cat visual cortex depend on N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA 86:5183-5187; 1989.
24. Monaghan, D.; Bridages, R.; Cotman, C. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:365-402; 1989.
25. Morari, M.; O'Connor, W. T.; Ungerstedt, U.; Fuxe, K. N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: An in vivo microdailysis study. J. Neurochem. 60:1884-1893; 1993.
26. 2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid. Eur. J. Pharmacol. 256:23-30; 1994.
27. Morgan, C. D.; Cattabeni, F.; Costa, E. Methamphetamine, denfluramine and their N-dealkylated metabolites: Effects on monoamine concentrations in rat tissues. J. Pharmacol. Exp. Ther. 180:127-135; 1972.
28. Nakanishi, S. Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603; 1992.
29. Nestler, E. J. Molecular neurobiology of drug addiction. Neuropsychopharmacology 11:77-87; 1994.
30. Ohmori, T.; Abekawa, A.; Muraki, A.; Koyama, T. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol. Biochem. Behav. 48:587-591; 1994.
31. Ohno, M.; Yoshida, H.; Watanabe, S. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: Relation to behavioral sensitization. Brain Res. 665:135-140; 1994.
32. Peat, M. A.; Gibb, J. W. High-performance liquid Chromatographic determination of indoleamines, dopamine and norepinephrine in rat brain with fluorometric detection. Anal. Biochem. 128:275-281; 1983.
33. Peat, M. A.; Warren, P. F.; Bakhit, C.; Gibb, J. W. The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: Evidence for differences in the effects of methamphetamine and amphetamine. Eur. J. Pharmacol. 116:11-16; 1985.
34. Ricaurte, G. A.; Fuller, R. W.; Perry, K. W.; Seiden, L. S.; Schuster, C. R. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of D-methamphetamine and amphetamine. Neuropharmacology 22:1165-1173; 1983.
35. Salin, P.; Chesselet, M. F. Paradoxical increase in striatal neuropeptide gene expression following ischemic lesions of the cerebral cortex. Proc. Natl. Acad. Sci. USA 89:9954-9958; 1992.
36. Sato, K.; Kiyama, H.; Tohyama, M. The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR 1-4) in the rat brain. Neuroscience 52:515-539; 1993.
37. Singh, N. A.; Midgley, L. P.; Bush, L. G.; Gibb, J. W.; Hanson, G. R. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems. Brain Res. 555:233-238; 1991.
38. Smith, A. J. W.; McGinty, J. F. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res. 21:359-362; 1994.
39. Snyder-Keller, A. M. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: Importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113:155-165; 1991.
40. 5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: Quantitative radioimmunocytochemical and in situ hybridization evidence. Mol. Brain Res. 8:143-158; 1990.
41. 5-enkephalin biosynthesis in neurons of the rat striatum. J. Pharmacol. Exp. Ther. 262:823-833; 1992.
42. Standaert, D. G.; Testa, C. M.; Young, A. B.; Penney, J. B., Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol. 343:1-16; 1994.
43. Stewart, J.; Druhan, J. P. The development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetitive NMDA receptor antagonist, MK-801. Psychopharmacology 110:125-132; 1993.
44. Tallaksen-Greene, S. J.; Wiley, R. G.; Albin, R. L. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res. 594:165-170; 1992.
45. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. A family of metabotropic glutamate receptors. Neuron 8:168-179; 1991.
46. Thanos, P. K.; Jhamandas, K.; Beninger, R. J. N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: Antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol. Brain Res. 589:55-61; 1991.
47. Torres, G.; Rivier, C. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res. Bull. 30:173-176; 1993.
48. Uhl, G. R.; Navia, B.; Douglass, J.; Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: High levels of preproenkephalin expression depend on cerebral cortical afferents. J. Neurosci. 8:4755-4764; 1988.
49. Vaccarino, F. M.; Hayward, M. D.; Nestler, E. J.; Duman, R. S.; Tallman, J. F. Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons. Mol. Brain Res. 12:233-241; 1992.
50. Wang, J. Q.; Daunais, J. B.; McGinty, J. F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18:343-353; 1994.
51. Wang, J. Q.; Daunais, J. B.; McGinty, J. F. Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Mol. Brain Res. 27:118-126; 1994.
52. Wang, J. Q.; McGinty, J. F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:262-274; 1995.
53. Wang, J. Q.; McGinty, J. F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J. Pharmacol. Exp. Ther. 273:909-917; 1995.
54. Wang, J. Q.; Smith, A. J. W.; McGinty, J. F. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin mRNA expression in rat forebrain. Neuroscience 68:83-95; 1995.
55. Weihmuller, F. B.; O'Dell, S. J.; Cole, B. N.; Marshall, J. F. MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: An in vivo microdialysis study. Brain Res. 549:230-235; 1991.
56. Witkin, J. M. Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci. 53:405-410; 1993.
57. Wolf, M. E.; Jeziorski, M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613:291-294; 1993.
58. Wolf, M. E.; Khansa, M. R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulation effects but blocks sensitization to amphetamine. Brain Res. 562:164-168; 1991.
59. Young, W. S.; Mezey, E.; Siegel, R. E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70:198-203; 1986.